C WorldWide Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

C WorldWide Group’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-23,076	Closed	-$2.14M	–	127
2016 Q1	$2.14M	Sell	23,076 -8,200	-26%	-$819K	0.04%	69
2015 Q4	$6.27M	Hold	31,276	–	–	0.11%	51
2015 Q3	$4.67M	Buy	31,276 +6,676	+27%	+$4.9M	0.08%	54
2015 Q2	$23.3M	Buy	24,600 +300	+1%	+$245K	0.33%	29
2015 Q1	$17.8M	Buy	24,300 +20,378	+520%	+$15.3M	0.25%	33
2014 Q4	$3.12M	Sell	3,922 -1,078	-22%	-$580K	0.05%	60
2014 Q3	$2M	Buy	+5,000	New	+$1.34M	0.03%	78

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

C WorldWide Group's TTPH Position: Q2 2016 in Review

C WorldWide Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 23,076 shares — an estimated $2.14M sold.

C WorldWide Group first reported a position in TTPH in Q3 2014 and held it in 7 quarters. The position peaked at $23.3M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

C WorldWide Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
C WorldWide Group sold 23,076 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $2.14M.
C WorldWide Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 7 quarters.
C WorldWide Group's Tetraphase Pharmaceuticals, Inc. position peaked at $23.3M in Q2 2015.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on C WorldWide Group's 13F filing for Q2 2016, filed 29 Jul 2016.